Belarus's national population-based cancer registry, kept at the N.N. Alexandrov National Cancer Centre. It says it registers all cases of malignant tumours in the country, and it is the source of the national cancer figures and of many studies of cancer after Chernobyl.
The Ministry of Health's account to the WHO and IARC mission of 2011 says that cancer registration on paper was introduced in Belarus in 1953, a computerised system was created in 1978, and the current automated information system on oncology was introduced in 1997; diagnoses are coded in ICD-10, and in situ cancers (D00 to D09) have been coded since 2004. The N.N. Alexandrov National Cancer Centre's history says the registry's foundations were laid in 1972 to 1973 and that it became a separate unit of the centre in 2011, describing it as the most complete information resource on all patients with malignant tumours registered in the country, built on the automated system for following up cancer patients. It shares the centre's coordinates, an approximate point.
The registry publishes a book, Cancer in Belarus: figures and facts. The centre announced on 28 February 2020 the edition analysing 2009 to 2018 (authors Okeanov, Moiseev, Levin, Evmenenko and Ipatiy), covering incidence, mortality, diagnosis, long-term results and the number of patients under follow-up; the notice told staff where to collect a copy. On 17 November 2026 the centre's website linked four later editions, for 2012 to 2021, 2013 to 2022, 2014 to 2023 and 2015 to 2024. The 2015 to 2024 edition (Minsk 2025) says the registry has functioned since 1972 and counts 59,058 new cases of malignant neoplasms registered in 2024, a total that includes basal-cell skin cancer (17.3% of cases). Studies built on its data include 30-year trends in uterine cancer (928 cases in 1993, 2,539 in 2022), thyroid cancer trends after Chernobyl from 1980 to 2019, second cancers among 30,568 people with papillary thyroid cancer, and blood cancers in the two most contaminated regions from 1978 to 2018. The blood cancer study was led from IARC, and the second-cancer study had co-authors in Switzerland, Germany, the United Kingdom, the United States and China.
Outside the thyroid, the low protracted doses in the most contaminated parts of Belarus have not shown a clear effect on blood cancers in population data.
Womb cancer has become much more common in Belarus, including in younger women, while earlier diagnosis and treatment have improved survival.
The thyroid cancer wave in Belarus follows the exposed generation as it ages, while a separate rise in unexposed young people is also under way.
People treated for thyroid cancer in Belarus have a raised risk of a second cancer and may benefit from follow-up that looks for it.
Most children who developed thyroid cancer after Chernobyl survived long term despite advanced disease at diagnosis; the authors recommend total thyroidectomy with radioactive iodine to reduce relapse.
Confirms, with doses estimated from individual thyroid measurements, that radioactive iodine from Chornobyl raised thyroid cancer risk in Belarusians exposed as children or adolescents.
Shares N.N. Alexandrov National Cancer Centre of Belarus, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares N.N. Alexandrov National Cancer Centre of Belarus, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares N.N. Alexandrov National Cancer Centre of Belarus, International Agency for Research on Cancer (IARC / WHO), Breast cancer (all types).
Shares Ministry of Health of the Republic of Belarus, N.N. Alexandrov National Cancer Centre of Belarus.
Shares International Agency for Research on Cancer (IARC / WHO), Thyroid cancer, Cervical cancer, Breast cancer (all types).
Shares International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares International Agency for Research on Cancer (IARC / WHO), Thyroid cancer, Breast cancer (all types).
Shares International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/